Drug intelligence / Profile preview

omega-3-acid ethyl ester

Development stage
Approved
Lead developer
Reliant
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3-acid ethyl ester is a prescription medication composed primarily of the ethyl esters of two long-chain omega-3 polyunsaturated fatty acids found in fish oil—eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It is used as an adjunct to diet to reduce very high triglyceride levels (≥500 mg/dL) in adults. The drug works by reducing hepatic production of triglycerides, increasing fatty acid metabolism through enhanced beta-oxidation, inhibiting the release of free fatty acids by competing for enzymes involved in triglyceride synthesis, increasing clearance via lipoprotein lipase activity, and decreasing production of very low-density lipoprotein cholesterol (VLDL-C). The exact mechanism is not fully understood. Omega-3-acid ethyl ester may also modestly increase HDL ("good" cholesterol), but can raise LDL ("bad" cholesterol) in some patients. It is taken orally as a liquid-filled capsule[1][4][5][6].

Brand names
LovazaOmtryg
Other names
omega-3-acid ethyl estersomega3-acid ethyl estersomega 3-acid ethyl estersomega-3 fatty acid ethyl estersomega3 fatty acid ethyl estersomega 3 fatty acid ethyl estersEPA/DHA ethyl esters
02

Targets

DGAT1 (Diacylglycerol O-acyltransferase 1)LPL (Lipoprotein lipase)SREBP-1 / SREBF1 (SREBP-1)

Beyond the preview

Go deeper on omega-3-acid ethyl ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3-acid ethyl ester.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call